Renal Cell Carcinoma

Title	Topic	First Author	Journal	Year	Views
Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists	Reporting standards	Davenport	Abdominal Radiology	2016	16
How I do it: evaluating renal masses	Evaluating renal masses	Israel	Radiology	2005	4
Management of the incidental renal mass	Incidental renal mass	Silverman	Radiology	2008	4
The current radiological approach to renal cysts	Cystic renal masses	Bosniak	Radiology	1986	1
Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system	Cystic renal masses	Israel	Radiology	2004	2
The Bosniak renal cyst classification: 25 years later	Cystic renal masses	Bosniak	Radiology	2011	5
CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat	Angiomyolipoma	Bosniak	AJR	1988	1
Diagnosis of renal angiomylolipoma with Hounsfield Unit thresholds: effect of size of region of interest and nephrographic phase imaging	Angiomyolipoma	Davenport	Radiology	2011	2
Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management	Angiomyolipoma	Jinzaki	Abdominal Imaging	2014	3
Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation	Renal mass histology	Prasad	RadioGraphics	2006	4

Title	Topic	First Author	Journal	Year	Views
Magnetic resonance imaging as a biomarker in renal cell carcinoma	MRI subtyping	Pedrosa	Cancer	2009
Diagnostic accuracy of multiparametric magnetic resonance imaging to identify clear cell renal cell carcinoma in T1a renal masses	MRI subtyping	Canvasser	J Urology	2017
Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?	Angiomyolipoma	Hindman	Radiology	2012
Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma	Angiomyolipoma	Chaudhry	AJR	2012
Differentiation of papillary renal cell carcinoma subtypes on CT and MRI	papillary renal cell carcinoma	Egbert	AJR	2013
Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation	Hyperattenuating renal mass	Silverman	RadioGraphics	2007
MR imaging of renal masses: correlation with findings at surgery and pathologic analysis	MRI subtyping	Pedrosa	RadioGraphics	2008
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging	Angiomyolipoma	Sasiwimonphan	Radiology	2012
Renal masses: characterization with diffusion-weighted MR imaging–a preliminary experience	Diffusion-weighted imaging	Zhang	Radiology	2008
Usefulness of diffusion-weighted imaging in the evaluation of renal masses	Diffusion-weighted imaging	Sandrasegaran	AJR	2010
Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT	MRI subtyping	Young	Radiology	2013	3
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease	Papillary renal cell carcinoma	Vikram	RadioGraphics	2009
Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings	Dynamic contrast enhancement	Sun	Radiology	2009

Title	Topic	First Author	Journal	Year	Views
Renal masses in the adult patient: the role of percutaneous biopsy	Renal mass biopsy	Silverman	Radiology	2006	1
Role of percutaneous needle biopsy for renal masses	Renal mass biopsy	Caoili	Semin Interv Radiol	2014	2
Incompletely characterized incidental renal masses: emerging data support conservative management	Renal mass biopsy and active surveillance	Silverman	Radiology	2015	1
Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology	Renal mass biopsy	Halverson	J Urology	2013	1

Title	Topic	First Author	Journal	Year	Views
Imaging-guided percutaneous ablation of renal cell carcinoma	Ablation	Uppot	AJR	2009
Percutaneous ablation in the kidney	Ablation	Venkatesan	Radiology	2011
Renal cell carcinoma: clinical experience and technical success with radiofrequency ablation of 42 tumors	Ablation	Gervais	Radiology	2003
Imaging-guided radiofrequency ablation of renal masses	Ablation	Zagoria	RadioGraphics	2004
Radiofrequency ablation of renal cell carcinoma: part I, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors	Ablation	Gervais	AJR	2005
Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors	Ablation	Gervais	AJR	2005
Imaging-guided radiofrequency ablation of cystic renal neoplasms	Ablation	Allen	AJR	2013
Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging	Ablation	Allen	RadioGraphics	2010
Cryoablation versus radiofrequency ablation for renal tumor ablation: time to reassess?	Ablation	Gervais	JVIR	2013
MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation	Post-ablation imaging	Davenport	AJR	2009
CT and MR imaging after imaging-guided thermal ablation of renal neoplasms	Post-ablation imaging	Wile	RadioGraphics	2007
Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging	Post-ablation imaging	Kawamoto	RadioGraphics	2007

Title	Topic	First Author	Journal	Year	Views
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma	Systemic therapy	Motzer	NEJM	2007	1
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT	Treatment response	Fournier	Radiology	2010	1
Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT	Treatment response	Smith	AJR	2010
Morphology, attenuation, size, and structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy	Treatment response	Smith	AJR	2010	1
Vascular tumor burden as a new quantitative CT biomarker for predicting metastatic RCC response to antiangiogenic therapy	Treatment response	Smith	Radiology	2016	1